Skip to content

Author

Tsai-Ching Hsu

We have 3 of 29 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Early urate-lowering therapy and cardiometabolic risk in adults without documented major cardiometabolic disease: a real-world cohort study

Background Whether urate-lowering therapy (ULT) affects cardiometabolic outcomes in individuals without established metabolic disease remains uncertain. Materials and methods This retrospective cohort study used TriNetX data (2015–2023) to include adults with newly diagnosed hyperuricemia (UA >7 mg/dL) and no baseline...

An-Ping Huo, Shiow-Ing Wang, Pui-Ying Leong et al. · 0 citations
Review Sep 2026

Structured exercise interventions and survival outcomes in patients with cancer: systematic review and meta-analysis of randomised controlled trials

The results support consideration of structured exercise as an effective adjuvant therapy in oncological care, with potential survival and recurrence benefits that extend beyond its traditional role in improving quality of life.

Chih-Chen Tzang, Chiao-An Luo, Vicky Fu-Hsuan Kuo et al. · 0 citations
Open access Aug 2026

Tumor‐Targeted Hyaluronic Acid/Tannic Acid‐Engineered Oxygen Nanogenerators With IR780 Payloads Enable Dual‐Mode Glutathione Depletion and Effective Singlet Oxygen Generation for Melanoma Treatment

This work provides an effective nanoplatform integrating tumor targeting, oxygen self-supply, and dual-mode GSH depletion to potentiate synergistic PTT/PDT for melanoma therapy.

Chai-How Hsu, I-Ju Liu, Hsiang-Yun Chih et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.